Martingale Asset Management’s Ultragenyx Pharmaceutical RARE Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2023
Q3 | – | Sell |
-5,406
| Closed | -$249K | – | 838 |
|
2023
Q2 | $249K | Hold |
5,406
| – | – | ﹤0.01% | 728 |
|
2023
Q1 | $217K | Hold |
5,406
| – | – | ﹤0.01% | 767 |
|
2022
Q4 | $250K | Hold |
5,406
| – | – | ﹤0.01% | 749 |
|
2022
Q3 | $224K | Buy |
5,406
+1,200
| +29% | +$49.7K | ﹤0.01% | 763 |
|
2022
Q2 | $251K | Buy |
+4,206
| New | +$251K | ﹤0.01% | 767 |
|